WFDC2 and endometrial cancer: Serum HE4 has also been shown to correlate with adverse endometrial cancer histopathological parameters, although the evidence has been limited by marked heterogeneity across the various studies, small sample sizes and significant variation in the prognostic thresholds used (74).